Three-dimensional-software developer TeraRecon has formed a strategic alliance with Japanese camera company Pentax for medical endoscopic imaging and consumer digital camera applications. Pentax has also taken an equity stake in the San Mateo, CA-based firm.
Under the terms of the deal, Pentax of Tokyo gains rights to include TeraRecon's signal and image processing and software technologies, in products for any market, with certain exceptions mutually agreed upon between the companies. TeraRecon will also conduct a feasibility study to evaluate the application of TeraRecon's technology in areas such as optical endoscopic imaging and consumer digital camera applications.
With a favorable outcome to the feasibility study, a first new product could be delivered within two years of the beginning of the study, TeraRecon said. The companies said they would also explore the potential for enterprise-wide distribution of endoscopic examinations using TeraRecon’s processor area network technology, as well as a variety of new technological approaches including the potential for quasi-3D rendering from optical endoscopic images.
Pentax paid $5.6 million for the 2.18% stake in TeraRecon.
By AuntMinnie.com staff writersJune 24, 2004
Related Reading
Fuji invests $5 million in TeraRecon, June 10, 2004
TeraRecon enters flat-panel area detector market, June 8, 2004
TeraRecon, University of MD team up in live 3-D exhibit, May 20, 2004
Road to RSNA, TeraRecon, November 20, 2003
Copyright © 2004 AuntMinnie.com
